9p21抑癌基因座单倍体缺陷通过骨髓微环境驱动髓系疾病
研究报道9p21同源基因座单等位或双等位缺失的小鼠会发生致死性MDS/MPN样疾病,伴骨髓异常骨小梁形成和/或纤维化;相互骨髓移植和条件性靶向提示疾病起源于骨髓基质;单细胞分析显示软骨细胞和成骨前体扩增、Cxcl12表达降低,循环Cxcl12降低而Cxcl13和骨桥蛋白/Spp1上调。
要点
- 9p21s单等位或双等位缺失小鼠发生致死性MDS/MPN样疾病。
- 相互骨髓移植和条件性靶向提示疾病起源于骨髓基质。
- 9p21s缺陷骨髓基质中软骨细胞和成骨前体扩增,Cxcl12表达降低。
核心结论
- 本研究强调骨髓微环境中的突变有潜力驱动MDS/MPN样疾病。
研究设计与样本
- 研究使用9p21同源基因座(9p21s)生殖系单等位缺失或诱导性双等位缺失小鼠,并结合相互骨髓移植和条件性靶向。
主要发现
- 9p21s单等位或双等位缺失小鼠发生致死性MDS/MPN样疾病,伴骨髓异常骨小梁形成和/或纤维化。
- 相互骨髓移植和条件性靶向提示疾病起源于骨髓基质。
- 9p21s缺陷骨髓基质单细胞分析显示软骨细胞和成骨前体扩增,体外成骨分化增加。
- 9p21s缺陷骨髓基质中维持造血干/祖细胞的因子表达降低,包括Cxcl12。
- 9p21s缺陷小鼠循环Cxcl12水平降低,同时促纤维化趋化因子Cxcl13及成骨和纤维化相关多功能糖蛋白骨桥蛋白/Spp1上调。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The chromosome 9p21 locus comprises several tumor suppressor genes including MTAP, CDKN2A, and CDKN2B, and its homo- or heterozygous deletion is associated with reduced survival in multiple cancer types. We report that mice with germ line monoallelic deletion or induced biallelic deletion of the 9p21-syntenic locus (9p21s) developed a fatal myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN)-like disease associated with aberrant trabecular bone formation and/or fibrosis in the bone marrow (BM). Reciprocal BM transfers and conditional targeting of 9p21s suggested that the disease originates in the BM stroma. Single-cell analysis of 9p21s-deficient BM stroma revealed the expansion of chondrocyte and osteogenic precursors, reflected in increased osteogenic differentiation in vitro. It also showed reduced expression of factors maintaining hematopoietic stem/progenitor cells, including Cxcl12. Accordingly, 9p21s-deficient mice showed reduced levels of circulating Cxcl12 and concomitant upregulation of the profibrotic chemokine Cxcl13 and the osteogenesis- and fibrosis-related multifunctional glycoprotein osteopontin/Spp1. Our study highlights the potential of mutations in the BM microenvironment to drive MDS/MPN-like disease.
引用
- Feng J, Hsu PF, Esteva E, et al. Haplodeficiency of the 9p21 tumor suppressor locus causes myeloid disorders driven by the bone marrow microenvironment. Blood. 2023. PMID: 37267505. doi:10.1182/blood.2022018512
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。